Temat: "Biomarkers" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Machine learning and experimental validation of novel biomarkers for hypertrophic cardiomyopathy and cancers.
Autorzy:: Dai H; Cardiovascular Center, The Affiliated Hospital of Yunnan University, Yunnan University, Kunming, Yunnan, China.; School of Medicine, Yunnan University, Kunming, Yunnan, China.
Liu Y; Department of Gynecology, Yunnan Cancer Hospital and The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Zhu M; Department of Geriatrics, The Affiliated Huaian Hospital of Xuzhou Medical University, Huaian Second People's Hospital, Huaian, Jiangsu, China.
Tao S; Cardiovascular Center, The Affiliated Hospital of Yunnan University, Yunnan University, Kunming, Yunnan, China.
Hu C; Cardiovascular Center, The Affiliated Hospital of Yunnan University, Yunnan University, Kunming, Yunnan, China.
Luo P; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Jiang A; Department of Urology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Zhang G; Cardiovascular Center, The Affiliated Hospital of Yunnan University, Yunnan University, Kunming, Yunnan, China.; School of Medicine, Yunnan University, Kunming, Yunnan, China.; Pokaż więcej
Źródło:: Journal of cellular and molecular medicine [J Cell Mol Med] 2024 Aug; Vol. 28 (16), pp. e70034.
Typ publikacji:: Journal Article
MeSH Terms:: Cardiomyopathy, Hypertrophic*/metabolism
Cardiomyopathy, Hypertrophic*/diagnosis
Cardiomyopathy, Hypertrophic*/genetics
Machine Learning*
Neoplasms*/metabolism
Neoplasms*/diagnosis
Neoplasms*/genetics
Neoplasms*/pathology
Biomarkers*/metabolism
Humans ; Male ; Female ; Prognosis ; Biomarkers, Tumor/metabolism ; Biomarkers, Tumor/genetics ; Middle Aged ; Nomograms

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 2.

Tytuł:: Potential Diagnostic Role of Serum Fibroblast Growth Factor-19 in Hepatocellular Carcinoma.
Autorzy:: Rashad AH; Clinical Oncology Department, Cairo University, Cairo, Egypt.
Oraby M; Hepato-gastroenterology and Endemic Medicine Department, Student's Hospital, Cairo University, Cairo, Egypt.
Abdelaal AA; Clinical and Chemical Pathology, Cairo University, Cairo, Egypt.
Salem AE; Internal Medicine Cairo University, Cairo, Egypt.
Maher RM; Hepato-gastroenterology and Endemic Medicine Department, Student's Hospital, Cairo University, Cairo, Egypt.
Abdo Abdelalem M; Endemic Medicine and Hepatology, Cairo University, Cairo, Egypt.; Pokaż więcej
Źródło:: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2024 Sep 01; Vol. 25 (9), pp. 3097-3104. Date of Electronic Publication: 2024 Sep 01.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/blood
Carcinoma, Hepatocellular*/diagnosis
Liver Neoplasms*/blood
Liver Neoplasms*/diagnosis
Biomarkers, Tumor*/blood
Fibroblast Growth Factors*/blood
Prothrombin*
alpha-Fetoproteins*/metabolism
alpha-Fetoproteins*/analysis
Protein Precursors*/blood
Liver Cirrhosis*/blood
Liver Cirrhosis*/diagnosis
Humans ; Case-Control Studies ; Male ; Female ; Middle Aged ; Prognosis ; Follow-Up Studies ; Adult ; Aged ; Biomarkers

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 3.

Tytuł:: Identification and Validation of STC1 Act as a Biomarker for High-Altitude Diseases and Its Pan-Cancer Analysis.
Autorzy:: Li Q; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210003, China.; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210003, China.
Xu Z; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210003, China.; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210003, China.
Gong Q; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210003, China.; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210003, China.
Shen X; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210003, China.; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210003, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 21; Vol. 25 (16). Date of Electronic Publication: 2024 Aug 21.
Typ publikacji:: Journal Article
MeSH Terms:: Altitude Sickness*/genetics
Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Glycoproteins*/genetics
Glycoproteins*/metabolism
Neoplasms*/genetics
Neoplasms*/metabolism
Humans ; Altitude ; Biomarkers ; Prognosis ; Tumor Microenvironment/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Therapy-Induced Senescence: Novel Approaches for Markers Identification.
Autorzy:: Pacifico F; Istituto per l'Endocrinologia e l'Oncologia Sperimentale, CNR, Via S. Pansini 5, 80131 Naples, Italy.
Magni F; Proteomics and Metabolomics Unit, Department of Medicine and Surgery, University of Milano-Bicocca, 20854 Vedano al Lambro, Italy.
Leonardi A; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, University of Naples 'Federico II', Via S. Pansini 5, 80131 Naples, Italy.
Crescenzi E; Istituto per l'Endocrinologia e l'Oncologia Sperimentale, CNR, Via S. Pansini 5, 80131 Naples, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 02; Vol. 25 (15). Date of Electronic Publication: 2024 Aug 02.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Neoplasms*/metabolism
Neoplasms*/pathology
Cellular Senescence*
Biomarkers, Tumor*/metabolism
Tumor Microenvironment*
Senescence-Associated Secretory Phenotype*
Humans ; Animals ; Biomarkers ; Senotherapeutics/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Integrated diagnostics, complex biomarkers, and a new frontier for tissue pathology.
Autorzy:: Salto-Tellez M; Integrated Pathology Unit, Division of Molecular Pathology, The Institute of Cancer Research London and The Royal Marsden Hospital, Sutton, UK.; Precision Medicine Centre of Excellence, The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Eloy C; Department of Pathology, IPATIMUP (Institute of Molecular Pathology and Immunology of University of Porto) & I3S-Instituto de Investigação e Inovação em Saúde & Pathology Department, Medical Faculty of Porto University, Porto, Portugal.
Laurinavicius A; Institute of Biomedical Sciences of the Faculty of Medicine of Vilnius University & National Center of Pathology affiliate of Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Fraggetta F; Pathology Unit, ASP Catania, 'Gravina' Hospital, Caltagirone, Italy.; Pokaż więcej
Źródło:: Histopathology [Histopathology] 2024 Oct; Vol. 85 (4), pp. 562-565.
Typ publikacji:: Editorial
MeSH Terms:: Biomarkers, Tumor*/analysis
Humans ; Neoplasms/diagnosis ; Neoplasms/pathology ; Biomarkers/metabolism ; Artificial Intelligence

Opinia redakcyjna

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 6.

Tytuł:: Magnetic augmentation through multi-gradient coupling enables direct and programmable profiling of circulating biomarkers.
Autorzy:: Chen Y; Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore.; Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore, Singapore.
Zhang L; Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore.; Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore, Singapore.
Wu X; Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore.
Sun X; Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore.
Sundah NR; Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore.; Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore, Singapore.
Wong CY; Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Natalia A; Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore.; Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore, Singapore.
Tam JKC; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Lim DW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.; Centre for Clinician-Scientist Development, Duke-NUS Medical School, Singapore, Singapore.
Chowbay B; Centre for Clinician-Scientist Development, Duke-NUS Medical School, Singapore, Singapore.; Clinical Pharmacology Laboratory, National Cancer Centre Singapore, Singapore, Singapore.; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.
Ang BT; National Neuroscience Institute, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore.
Tang C; National Neuroscience Institute, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore.; SG Enable, Innovation, Singapore, Singapore.
Loh TP; Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore.; Department of Laboratory Medicine, National University Hospital, Singapore, Singapore.
Shao H; Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore. .; Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore, Singapore. .; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. .; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore. .; Pokaż więcej
Źródło:: Nature communications [Nat Commun] 2024 Sep 27; Vol. 15 (1), pp. 8410. Date of Electronic Publication: 2024 Sep 27.
Typ publikacji:: Journal Article
MeSH Terms:: Biosensing Techniques*/methods
Biomarkers, Tumor*/blood
Humans ; Hydrogels/chemistry ; Magnetite Nanoparticles/chemistry ; Magnetics ; Biomarkers/blood ; RNA/blood ; Magnetic Fields ; Neoplasms/blood

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 7.

Tytuł:: Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy.
Autorzy:: Saeki I; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Shimose S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Tomonari T; Department of Gastroenterology and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School of Medicine, Tokushima, Japan.
Ito T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Tani J; Department of Gastroenterology and Neurology, Kagawa University, Faculty of Medicine, Kagawa, Japan.
Takeuchi Y; Department of Regenerative Medicine, Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
Yoshioka N; Department of Gastroenterology and Hepatology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Aichi, Japan.
Naito T; Department of Gastroenterology, Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan.
Takeuchi M; Department of Gastroenterology, Anjo Kosei Hospital, Anjo, Japan.
Kakizaki S; Department of Clinical Research, NHO Takasaki General Medical Center, Takasaki, Gunma, Japan.
Hatanaka T; Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Maebashi, Japan.
Sasaki K; Department of Gastroenterology and Hepatology, Kawasaki Medical School, Kurashiki, Japan.
Yasunaka T; Department of Gastroenterology, Fukuyama City Hospital, Okayama, Japan.
Sakata M; Department of Gastroenterology, NHO Fukuyama Medical Center, Fukuyama, Japan.
Iwamoto H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.; Iwamoto Internal Medical Clinic, Kitakyusyu, Japan.
Itano S; Department of Gastroenterology and Hepatology, Kurume Central Hospital, Kurume, Japan.
Shirono T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Tanabe N; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.; Division of Laboratory, Yamaguchi University Hospital, Yamaguchi, Japan.
Yamamoto T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Kanayama Y; Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Maebashi, Japan.
Naganuma A; Department of Gastroenterology, NHO Takasaki General Medical Center, Takasaki, Gunma, Japan.
Nishina S; Department of Gastroenterology and Hepatology, Kawasaki Medical School, Kurashiki, Japan.
Otsuka M; Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Kobara H; Department of Gastroenterology and Neurology, Kagawa University, Faculty of Medicine, Kagawa, Japan.
Kawashima H; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Takayama T; Department of Gastroenterology and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School of Medicine, Tokushima, Japan.
Kawaguchi T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Yamasaki T; Department of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Takami T; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.; Pokaż więcej
Corporate Authors:: Hepatology InVestigator Experts in Japan (HIVE-J) Study Group
Źródło:: PloS one [PLoS One] 2024 Sep 25; Vol. 19 (9), pp. e0311084. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/blood
Carcinoma, Hepatocellular*/pathology
alpha-Fetoproteins*/metabolism
alpha-Fetoproteins*/analysis
Prothrombin*/metabolism
Liver Neoplasms*/drug therapy
Liver Neoplasms*/blood
Liver Neoplasms*/pathology
Antibodies, Monoclonal, Humanized*/therapeutic use
Antibodies, Monoclonal*/therapeutic use
Antibodies, Monoclonal*/administration & dosage
Protein Precursors*
Biomarkers, Tumor*/blood
Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Adult ; Prognosis ; Treatment Outcome ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Logistic regression and other statistical tools in diagnostic biomarker studies.
Autorzy:: Elkahwagy DMAS; Pharmaceutical Biology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, 11835, Egypt. .
Kiriacos CJ; Pharmaceutical Biology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, 11835, Egypt.
Mansour M; Pharmaceutical Biology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, 11835, Egypt.; Pokaż więcej
Źródło:: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Sep; Vol. 26 (9), pp. 2172-2180. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Biomarkers, Tumor*/analysis
Humans ; Logistic Models ; Biomarkers/analysis ; Neoplasms/diagnosis

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 9.

Tytuł:: Letter to editor 'Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease'.
Autorzy:: Tong B; Department of Clinical Laboratory, Jinhua Municipal Central Hospital, Jinhua Hospital of Zhejiang University, Jinhua, China.
Cheng W; Department of Clinical Laboratory, Linping Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, Zhejiang, China. .; Pokaż więcej
Źródło:: Clinical rheumatology [Clin Rheumatol] 2024 Sep; Vol. 43 (9), pp. 3037-3038. Date of Electronic Publication: 2024 Jul 22.
Typ publikacji:: Letter
MeSH Terms:: Arthritis, Rheumatoid*/complications
Lung Diseases, Interstitial*/complications
Lung Diseases, Interstitial*/etiology
Lung Diseases, Interstitial*/diagnosis
Biomarkers*/blood
Humans ; Biomarkers, Tumor/blood ; Inflammation

Opinia redakcyjna

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 10.

Tytuł:: Discovery of candidate biomarkers from plasma-derived extracellular vesicles of patients with cirrhosis and hepatocellular carcinoma: an exploratory proteomic study.
Autorzy:: Zertuche-Martínez C; Laboratorio de Fibrosis y cáncer, Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca de Juárez 68120, Oaxaca, Mexico.
Velázquez-Enríquez JM; Laboratorio de Fibrosis y cáncer, Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca de Juárez 68120, Oaxaca, Mexico.
González-García K; Laboratorio de Fibrosis y cáncer, Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca de Juárez 68120, Oaxaca, Mexico.
Santos-Álvarez JC; Laboratorio de Fibrosis y cáncer, Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca de Juárez 68120, Oaxaca, Mexico.
Romero-Tlalolini MLÁ; CONAHCYT-Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca de Juárez 68120, Oaxaca, Mexico. .
Pina-Canseco S; Centro de Investigación Facultad de Medicina UNAM UABJO, Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca de Juárez 68120, Oaxaca, Mexico.
Pérez-Campos Mayoral L; Centro de Investigación Facultad de Medicina UNAM UABJO, Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca de Juárez 68120, Oaxaca, Mexico.
Muriel P; Laboratorio de Hepatología Experimental, Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Ciudad de México 07000, Mexico.
Villa-Treviño S; Departamento de Biología Celular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Ciudad de México 07360, Mexico.
Baltiérrez-Hoyos R; CONAHCYT-Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca de Juárez 68120, Oaxaca, Mexico. .
Arellanes-Robledo J; CONAHCYT-Instituto Nacional de Medicina Genómica, Ciudad de México 14610, Mexico.
Vásquez-Garzón VR; CONAHCYT-Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca de Juárez 68120, Oaxaca, Mexico. .; Pokaż więcej
Źródło:: Molecular omics [Mol Omics] 2024 Aug 12; Vol. 20 (7), pp. 483-495. Date of Electronic Publication: 2024 Aug 12.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/blood
Carcinoma, Hepatocellular*/metabolism
Liver Neoplasms*/blood
Liver Neoplasms*/metabolism
Extracellular Vesicles*/metabolism
Liver Cirrhosis*/blood
Liver Cirrhosis*/metabolism
Proteomics*/methods
Biomarkers, Tumor*/blood
Humans ; Male ; Female ; Middle Aged ; Tandem Mass Spectrometry ; Proteome/metabolism ; Chromatography, Liquid ; Biomarkers/blood

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 11.

Tytuł:: Programming a Ferroptosis-to-Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy.
Autorzy:: Vinik Y; Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, 76100, Israel.
Maimon A; Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, 76100, Israel.
Dubey V; Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, 76100, Israel.
Raj H; Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, 76100, Israel.
Abramovitch I; The Ruth and Bruce Rappaport, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, 3525433, Israel.
Malitsky S; Metabolic Profiling Unit, Weizmann Institute of Science, Rehovot, 76100, Israel.
Itkin M; Metabolic Profiling Unit, Weizmann Institute of Science, Rehovot, 76100, Israel.
Ma'ayan A; Department of Pharmacological Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Westermann F; Neuroblastoma Genomics, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Gottlieb E; The Ruth and Bruce Rappaport, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, 3525433, Israel.
Ruppin E; Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Lev S; Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, 76100, Israel.; Pokaż więcej
Źródło:: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 May; Vol. 11 (17), pp. e2307263. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:: Ferroptosis*/genetics
Apoptosis*/genetics
Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Humans ; Animals ; Mice ; Female ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Disease Models, Animal ; Biomarkers/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.
Autorzy:: Wan J; Rheumatology and Immunology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Yu Z; Rheumatology and Immunology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Cao X; Rheumatology and Immunology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Zhao X; Rheumatology and Immunology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Zhou W; Rheumatology and Immunology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Zheng Y; Department of Rheumatology and Immunology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, No. 8 Gongti South Road, Chaoyang District, Beijing, 100016, China. zzyy90_.; Pokaż więcej
Źródło:: Clinical rheumatology [Clin Rheumatol] 2024 Jun; Vol. 43 (6), pp. 1855-1863. Date of Electronic Publication: 2024 May 05.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Diseases, Interstitial*/blood
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/complications
Lung Diseases, Interstitial*/etiology
Arthritis, Rheumatoid*/complications
Arthritis, Rheumatoid*/blood
Arthritis, Rheumatoid*/diagnosis
Biomarkers, Tumor*/blood
Humans ; Female ; Male ; Middle Aged ; Aged ; Biomarkers/blood ; ROC Curve ; Logistic Models ; Keratin-19/blood ; Adult ; C-Reactive Protein/analysis ; Severity of Illness Index ; CA-19-9 Antigen/blood ; Antigens, Neoplasm

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 13.

Tytuł:: Discovery of the potential biomarkers for early diagnosis of endometrial cancer via integrating metabolomics and transcriptomics.
Autorzy:: Fu Y; School of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China; Core Facilities and Centers, Hebei Medical University, Shijiazhuang, 050017, China.
Wang C; College of Basic Medicine, Hebei Medical University, Shijiazhuang, 050017, China.
Wu Z; School of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China.
Zhang X; Core Facilities and Centers, Hebei Medical University, Shijiazhuang, 050017, China; College of Basic Medicine, Hebei Medical University, Shijiazhuang, 050017, China.
Liu Y; School of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China.
Wang X; School of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China.
Liu F; School of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China.
Chen Y; School of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China.
Zhang Y; School of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China. Electronic address: .
Zhao H; Department of Obstetrics and Gynecology, The Fourth Hospital of Hebei Medical University, 050011, China. Electronic address: .
Wang Q; School of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China. Electronic address: .; Pokaż więcej
Źródło:: Computers in biology and medicine [Comput Biol Med] 2024 May; Vol. 173, pp. 108327. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Endometrial Neoplasms*/diagnosis
Endometrial Neoplasms*/genetics
Endometrial Neoplasms*/metabolism
Humans ; Female ; Early Detection of Cancer ; Biomarkers ; Metabolomics ; Gene Expression Profiling

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 14.

Tytuł:: Biomarker-driven molecular imaging probes in radiotherapy.
Autorzy:: Li H; Department of Radiology, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China.
Gong Q; Department of Radiology, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China.; Functional and Molecular Imaging Key Laboratory of Sichuan Province and Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu 610041, China.; Department of Radiology, West China Xiamen Hospital of Sichuan University, 699 Jinyuan Xi Road, Jimei District, 361021 Xiamen, Fujian, China.
Luo K; Department of Radiology, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China.; Functional and Molecular Imaging Key Laboratory of Sichuan Province and Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu 610041, China.; Pokaż więcej
Źródło:: Theranostics [Theranostics] 2024 Jul 02; Vol. 14 (10), pp. 4127-4146. Date of Electronic Publication: 2024 Jul 02 (Print Publication: 2024).
Typ publikacji:: Journal Article; Review
MeSH Terms:: Neoplasms*/radiotherapy
Neoplasms*/diagnostic imaging
Molecular Imaging*/methods
Biomarkers, Tumor*/metabolism
Humans ; Animals ; Molecular Probes/chemistry ; Radiotherapy/methods ; Radiotherapy/adverse effects ; Biomarkers/metabolism

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 15.

Tytuł:: Elevation of S2-bound α1-acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma.
Autorzy:: Oltmanns C; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School (MHH), Hannover, Germany.; Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH), Hannover, Germany.; Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany.; TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
Bremer B; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School (MHH), Hannover, Germany.; Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany.
Kusche L; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School (MHH), Hannover, Germany.
Stål P; Department of Medicine, Karolinska Institutet, Huddinge, Sweden.; Division of Hepatology, Department of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden.
Zenlander R; Department of Medicine, Karolinska Institutet, Huddinge, Sweden.; Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Tauwaldt J; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School (MHH), Hannover, Germany.; Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH), Hannover, Germany.; Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany.; TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
Rydén I; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Påhlsson P; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Cornberg M; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School (MHH), Hannover, Germany.; Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH), Hannover, Germany.; Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany.; TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.; German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Braunschweig, Germany.
Wedemeyer H; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School (MHH), Hannover, Germany.; Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany.; German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Braunschweig, Germany.; Pokaż więcej
Źródło:: Journal of viral hepatitis [J Viral Hepat] 2024 Jul; Vol. 31 (7), pp. 383-390. Date of Electronic Publication: 2024 Apr 12.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers*/blood
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/etiology
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/diagnosis
Liver Neoplasms*/diagnosis
Liver Neoplasms*/etiology
Orosomucoid*/metabolism
Orosomucoid*/analysis
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Antiviral Agents/therapeutic use ; Biomarkers, Tumor/metabolism ; Case-Control Studies ; Early Detection of Cancer ; Hepacivirus ; Retrospective Studies

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 16.

Tytuł:: Shared biomarkers and mechanisms in idiopathic pulmonary fibrosis and non-small cell lung cancer.
Autorzy:: Ding X; Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu, China.
Liu H; Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu, China.
Xu Q; Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu, China.
Ji T; Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu, China.
Chen R; Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu, China.
Liu Z; Department of Thoracic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu, China. Electronic address: .
Dai J; Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu, China. Electronic address: .; Pokaż więcej
Źródło:: International immunopharmacology [Int Immunopharmacol] 2024 Jun 15; Vol. 134, pp. 112162. Date of Electronic Publication: 2024 May 03.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/genetics
Idiopathic Pulmonary Fibrosis*/genetics
Idiopathic Pulmonary Fibrosis*/diagnosis
Lung Neoplasms*/genetics
Biomarkers, Tumor*/genetics
Humans ; Protein Interaction Maps ; Gene Expression Profiling ; Databases, Genetic ; Gene Expression Regulation, Neoplastic ; Gene Regulatory Networks ; Biomarkers ; Transcriptome

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 17.

Tytuł:: A preliminary study on the reference intervals of serum tumor marker in apparently healthy elderly population in southwestern China using real-world data.
Autorzy:: Miao Q; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Sichuan Clinical Research Center for Laboratory Medicine, Chengdu, Sichuan, China.; Clinical Laboratory Medicine Research Center of West China Hospital, No.37, Guoxue Xiang, Wuhou District, Chengdu, Sichuan, 610041, China.
Lei S; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Chen F; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Niu Q; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Sichuan Clinical Research Center for Laboratory Medicine, Chengdu, Sichuan, China.; Clinical Laboratory Medicine Research Center of West China Hospital, No.37, Guoxue Xiang, Wuhou District, Chengdu, Sichuan, 610041, China.
Luo H; Division of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. .; Sichuan Clinical Research Center for Laboratory Medicine, Chengdu, Sichuan, China. .; Clinical Laboratory Medicine Research Center of West China Hospital, No.37, Guoxue Xiang, Wuhou District, Chengdu, Sichuan, 610041, China. .
Cai B; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. .; Sichuan Clinical Research Center for Laboratory Medicine, Chengdu, Sichuan, China. .; Clinical Laboratory Medicine Research Center of West China Hospital, No.37, Guoxue Xiang, Wuhou District, Chengdu, Sichuan, 610041, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 May 29; Vol. 24 (1), pp. 657. Date of Electronic Publication: 2024 May 29.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers, Tumor*/blood
Prothrombin*
Humans ; Male ; Female ; Aged ; China/epidemiology ; Reference Values ; Middle Aged ; Aged, 80 and over ; Neoplasms/blood ; Neoplasms/epidemiology ; alpha-Fetoproteins/analysis ; Ferritins/blood ; CA-19-9 Antigen/blood ; Carcinoembryonic Antigen/blood ; CA-125 Antigen/blood ; Phosphopyruvate Hydratase/blood ; Keratin-19/blood ; Protein Precursors ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation.
Autorzy:: Qiao W; Interventional Therapy Center for Oncology, Beijing You'an Hospital, Capital Medical University, 8 Xitoutiao, Youanmenwai Street, Fengtai District, Beijing, People's Republic of China.; Beijing Di'tan Hospital, Capital Medical University, 8 Jingshun East Street, Chaoyang District, Beijing, People's Republic of China.; Changping Laboratory, Beijing, People's Republic of China.
Li J; Beijing Di'tan Hospital, Capital Medical University, 8 Jingshun East Street, Chaoyang District, Beijing, People's Republic of China.
Xiong Y; Interventional Therapy Center for Oncology, Beijing You'an Hospital, Capital Medical University, 8 Xitoutiao, Youanmenwai Street, Fengtai District, Beijing, People's Republic of China.
Zheng J; Interventional Therapy Center for Oncology, Beijing You'an Hospital, Capital Medical University, 8 Xitoutiao, Youanmenwai Street, Fengtai District, Beijing, People's Republic of China. .
Jin R; Beijing Di'tan Hospital, Capital Medical University, 8 Jingshun East Street, Chaoyang District, Beijing, People's Republic of China. .; Changping Laboratory, Beijing, People's Republic of China. .
Hu C; Interventional Therapy Center for Oncology, Beijing You'an Hospital, Capital Medical University, 8 Xitoutiao, Youanmenwai Street, Fengtai District, Beijing, People's Republic of China. .; Pokaż więcej
Źródło:: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 May 07; Vol. 150 (5), pp. 241. Date of Electronic Publication: 2024 May 07.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Liver Neoplasms*/surgery
Neoplasm Recurrence, Local*/pathology
alpha-Fetoproteins*/analysis
alpha-Fetoproteins*/metabolism
Nomograms*
Biomarkers*
Humans ; Female ; Male ; Middle Aged ; Prognosis ; Prothrombin ; Retrospective Studies ; Aged ; Protein Precursors ; Biomarkers, Tumor ; Adult ; ROC Curve ; Plant Lectins

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 19.

Tytuł:: The Usefulness of Vitamin K-Dependent Proteins in the Diagnosis of Colorectal Carcinoma.
Autorzy:: Perné MG; 4th Department-Internal Medicine, 4th Medical Discipline, Faculty of Medicine, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Republicii Street, Nr. 18, 400015 Cluj-Napoca, Romania.
Sitar-Tăut AV; 4th Department-Internal Medicine, 4th Medical Discipline, Faculty of Medicine, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Republicii Street, Nr. 18, 400015 Cluj-Napoca, Romania.
Orășan OH; 4th Department-Internal Medicine, 4th Medical Discipline, Faculty of Medicine, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Republicii Street, Nr. 18, 400015 Cluj-Napoca, Romania.
Negrean V; 4th Department-Internal Medicine, 4th Medical Discipline, Faculty of Medicine, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Republicii Street, Nr. 18, 400015 Cluj-Napoca, Romania.
Vlad CV; 4th Department-Internal Medicine, 4th Medical Discipline, Faculty of Medicine, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Republicii Street, Nr. 18, 400015 Cluj-Napoca, Romania.
Alexescu TG; 4th Department-Internal Medicine, 4th Medical Discipline, Faculty of Medicine, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Republicii Street, Nr. 18, 400015 Cluj-Napoca, Romania.
Milaciu MV; 4th Department-Internal Medicine, 4th Medical Discipline, Faculty of Medicine, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Republicii Street, Nr. 18, 400015 Cluj-Napoca, Romania.
Ciumărnean L; 4th Department-Internal Medicine, 4th Medical Discipline, Faculty of Medicine, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Republicii Street, Nr. 18, 400015 Cluj-Napoca, Romania.
Togănel RD; 6th Department-Surgery, 4th Surgery Discipline, Faculty of Medicine, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Republicii Street, Nr. 18, 400015 Cluj-Napoca, Romania.
Petre GE; 6th Department-Surgery, 4th Surgery Discipline, Faculty of Medicine, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Republicii Street, Nr. 18, 400015 Cluj-Napoca, Romania.
Șimon I; 6th Department-Surgery, 4th Surgery Discipline, Faculty of Medicine, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Republicii Street, Nr. 18, 400015 Cluj-Napoca, Romania.
Crăciun A; 2nd Department-Molecular Sciences, Discipline of Medical Biochemistry, Faculty of Medicine, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Pasteur Street, Nr. 6, 400349 Cluj-Napoca, Romania.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 May 03; Vol. 25 (9). Date of Electronic Publication: 2024 May 03.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers, Tumor*/blood
Colorectal Neoplasms*/blood
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/pathology
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Biomarkers ; CA-19-9 Antigen/blood ; Calcium-Binding Proteins/blood ; Carcinoembryonic Antigen/blood ; Extracellular Matrix Proteins/blood ; Liver Neoplasms/blood ; Liver Neoplasms/diagnosis ; Liver Neoplasms/secondary ; Matrix Gla Protein ; Protein Precursors/blood ; Prothrombin/metabolism ; ROC Curve ; Vitamin K/blood

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Identification and validation of serum metabolite biomarkers for endometrial cancer diagnosis.
Autorzy:: Liu W; Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, P. R. China.; School of Biomedical Engineering, Institute of Medical Robotics and Shanghai Academy of Experimental Medicine, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.; Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
Ma J; Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, P. R. China.
Zhang J; Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, P. R. China.; School of Biomedical Engineering, Institute of Medical Robotics and Shanghai Academy of Experimental Medicine, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.; Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
Cao J; Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, P. R. China.; School of Biomedical Engineering, Institute of Medical Robotics and Shanghai Academy of Experimental Medicine, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.; Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
Hu X; Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, P. R. China.
Huang Y; Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, P. R. China.; School of Biomedical Engineering, Institute of Medical Robotics and Shanghai Academy of Experimental Medicine, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.; Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
Wang R; Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, P. R. China.; School of Biomedical Engineering, Institute of Medical Robotics and Shanghai Academy of Experimental Medicine, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.; Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
Wu J; Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, P. R. China.; School of Biomedical Engineering, Institute of Medical Robotics and Shanghai Academy of Experimental Medicine, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.; Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
Di W; Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China. .; State Key Laboratory of Systems Medicine for Cancer, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, P. R. China. .
Qian K; Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China. .; State Key Laboratory of Systems Medicine for Cancer, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, P. R. China. .; School of Biomedical Engineering, Institute of Medical Robotics and Shanghai Academy of Experimental Medicine, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China. .; Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China. .
Yin X; Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China. .; State Key Laboratory of Systems Medicine for Cancer, Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, P. R. China. .; Pokaż więcej
Źródło:: EMBO molecular medicine [EMBO Mol Med] 2024 Apr; Vol. 16 (4), pp. 988-1003. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers, Tumor*/analysis
Endometrial Neoplasms*/diagnosis
Endometrial Neoplasms*/metabolism
Endometrial Neoplasms*/pathology
Female ; Humans ; Endometrium/chemistry ; Endometrium/metabolism ; Endometrium/pathology ; Biomarkers/metabolism ; Uterus ; Mass Spectrometry/methods

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Informacja

Wyszukujesz frazę ""Biomarkers"" wg kryterium: Temat